Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization of Hyaluronic Nasal Spray

Sensitivity, Contact Clinical Trial

Official title:
Dermatologist-supervised Assessment of Primary and Accumulated Irritation Potential and Skin Sensitization Potential for the NASAL SPRAY Product

Status Completed

Clinical Trial Summary

Evaluate the potential of Primary Dermal Irritability, Accumulated Dermal Irritability and Dermal Sensitization, of health products through the application of Patch Test, proving the safety of the product for topical use. The study will be conducted with a Brazilian sample in which 65 research participants will be included. Depending on the results, the present study may support the claim: dermatologically tested.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05508243
Study type	Interventional
Source	Herbarium Laboratorio Botanico Ltda
Contact
Status	Completed
Phase	N/A
Start date	October 17, 2022
Completion date	November 24, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04332445` - Dermatological Assessment of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Phototoxicity.	N/A
Completed	`NCT05508230` - Evaluation of Cutaneous Acceptability and Perceived Effectiveness of a Nasal Spray (Health Care Products)	N/A
Completed	`NCT04248556` - Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization	N/A
Completed	`NCT03375957` - Sensitization Study of ATx201 in Healthy Volunteers	Phase 1
Completed	`NCT04250623` - Dermatological Assessment of Photoallergy and Phototoxicity	N/A